4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-063801
Chief Reg & Develop Officer gave up 446 shares (to pay taxes)
- Chief Reg & Develop Officer acquired 1,625 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Powala Christopher Chief Reg & Develop Officer | 2018-12-18 | Option exercise | +1,625 | 139,889 | D | ||
| Powala Christopher Chief Reg & Develop Officer | 2018-12-18 | Shares withheld for taxes | −446 | $6.30 | $2,810 | 139,443 | D |
| Derivatives | |||||||
| Powala Christopher Chief Reg & Develop Officer | 2018-12-18 | Option exercise · Restricted Stock Units | −1,625 | 1,625 | D | ||
Loading xslF345X03/doc4.xml…